Clinical Trial Update: Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atomoxetine alone or in combination with buspirone for adults with Attention-Deficit/Hyperactivity Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Strattera) (Atomoxetine)
• Buspirone (Buspar) (Buspirone)

Snippet

Sponsor: Pfizer | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED